OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences

Drug and Alcohol Dependence

Volumn 110, Issue 1-2, 2010, Pages 156-159

  Covey, Lirio S ^a   Hu, Mei Chen ^b   Winhusen, Theresa ^c   Weissman, Judith ^d   Berlin, Ivan ^e   Nunes, Edward V ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b University of Cincinnati College of Medicine ^*  (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ADHD; OROS methylphenidate; Race ethnic differences; Smoking cessation

Indexed keywords

METHYLPHENIDATE; NICOTINE PATCH; PLACEBO;

ADOLESCENT SMOKING; ADULT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; ETHNIC DIFFERENCE; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; PATIENT ATTITUDE; PATIENT COUNSELING; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SMOKING CESSATION; SYMPTOM; TOBACCO DEPENDENCE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADMINISTRATION, CUTANEOUS; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG THERAPY, COMBINATION; ETHNIC GROUPS; FEMALE; FORECASTING; HUMANS; MALE; METHYLPHENIDATE; NICOTINE; NICOTINIC AGONISTS; PSYCHIATRIC STATUS RATING SCALES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

NICOTIANA TABACUM;

EID: 77953725597     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.02.002     Document Type: Article

References (14)

1. Adler L., Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. N Am. 2004, 27:187-201.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington DC. 4th ed.
3. Arnold L.E., Elliot M., Sachs L., Bird H., Kraemer H.C., Wells K.C., Abikoff H.B., Carda A., Conners C.K., Elliott G.R., Greenhill L.L., Hechtman L., Hindshaw S.P., Hoza B., Jensen P.S., March J.S., Newcorn J.H., Pelham W.E., Severe J.B., Swanson J.M., Vitiello B., Wigal T. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J. Consult. Clin. Psychol. 2003, 71:713-727.
4. Conners C.K., Levin E.D., Sparrow E., Hinton S.C., Erhardt D., Meck .W.H., Rose J.E., March J. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol. Bull. 1996, 32:67-73.
5. Covey L.S., Botello-Harbaum M., Glassman A.H., Masmela J., LoDuca C., Salzman V., Fried J. Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethn. Dis. 2008, 18:59-64.
6. Cropsey K.L., Weaver M.F., Eldridge G.D., Villalobos G.C., Best A.M., Stitzer M.L. Differential success rates in racial groups: Results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob. Res. 2009, 11:690-697.
7. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation 1998, Guilford Press, New York.
8. Etter J., Hughes J. A comparison of the psychometric properties of three cigarette withdrawal scales. Addiction 2006, 101:362-372.
9. Heatherton T.F., Kozlowski L.T., Becker C., Frecker R.C., Fagerstrom K.O. The fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addiction 1991, 86:1119-1127.
10. Miller N., Frieden T.R., Liu S.Y., Matte T.D., Mostashari F., Deitcher D.R., Cummings K.M., Chang C., Bauer U., Bassett M.T. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 2005, 365:1849-1854.
11. Miller T.W., Nigg J.T., Miller R.L. Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?. Clin. Psychol. Rev. 2008, 29:77-86.
12. Sobell L.C., Sobell M.B. Timeline follow back: a technique for assessing self-reported ethanol consumption. Techniques to Assess Alcohol Consumption 1992, 19-28. Humana Press, Inc, New Jersey. J. Allen, R. Litten (Eds.).
13. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-eficit/hyperactivity disorder. Arch. Gen. Psychiatry 2007, 64:932-940.
14. Winhusen, T., Somoza, E., Brigham, G.S., Liu, D., Green, C.A., Covey, L.S., Croghan, I.T., Adler, L.A., Weiss, R.D., Leimberger, J.D., Lewis, D.F., Dorer, E.M. Does treatment of attention deficit hyperactivity disorder (ADHD) enhance response to smoking cessation intervention in ADHD smokers? A randomized trial. J. Clin Psychiatry, in press.